Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules due to the presence of both hydroxyl and fluoromethyl functional groups, which enhance binding affinity and metabolic stability. Commonly employed in the production of selective receptor modulators, including those targeting neurotransmitter receptors. Also utilized in medicinal chemistry for the design of novel analogs in drug discovery programs, especially for neurological and psychiatric disorders.